BiotechTube
Home/Snyder Biomedical/John A. Martens
JA

John A. Martens

Co-Founder

Snyder Biomedical

Therapeutic Areas

OphthalmologyAge-Related Macular Degeneration

Snyder Biomedical Pipeline

DrugIndicationPhase
Oral L-DOPA/CarbidopaAdjunctive Treatment for Neovascular Age-Related Macular Degeneration (nAMD)Proof-of-Concept

Leadership Team at Snyder Biomedical

RW
Robert W. Snyder, MD, PhD
Co-Founder
View full Snyder Biomedical profile